Open Access

Transplantation of placenta‑derived multipotent cells in rats with dimethylhydrazine‑induced colon cancer decreases survival rate

  • Authors:
    • Hanna Svitina
    • Inessa Skrypkina
    • Pavlo Areshkov
    • Vitaliy Kyryk
    • Tetiana Bukreieva
    • Pavlo Klymenko
    • Liudmyla Garmanchuk
    • Galyna Lobintseva
    • Volodymyr Shablii
  • View Affiliations

  • Published online on: February 8, 2018     https://doi.org/10.3892/ol.2018.7996
  • Pages: 5034-5042
  • Copyright: © Svitina et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Transplantation of placenta-derived multipotent cells (PDMCs) is a promising treatment method for many diseases. However, the impact of PDMCs on colon cancer has not yet been studied. PDMCs were obtained from rat placentas by culturing tissue explants. Colon cancer was experimentally induced in male albino Wistar rats by administering 20 mg/kg dimethylhydrazine (DMH) once a week for 20 consecutive weeks. The administration of the PDMCs was performed at the 20th week after the first DMH injection. The number and size of each tumour lesion were calculated in the 5th week after transplantation. The tumour type was determined by standard histological methods. To study the engraftment of PDMCs in the body of rats, the cells were transduced with enhanced green fluorescent protein. Cell engraftment was determined by assessing the presence of EGFP by PCR and immunohistochemistry. Survival of all rats was monitored daily. Allogeneic transplantation of PDMCs to rats at middle phase of DMH‑induced colon carcinogenesis did not significantly influence the number of neoplasms and the parameters of mean and total tumour area, but led to an increase in size of the most invasiveness tumours. Intravenous allogeneic transplantation of PDMCs reduced the survival rate of rats with colon cancer by 17 days. PDMCs from rats engrafted into tissues of the normal intestine, tumours, lungs, liver, and spleen of rats for five weeks after intravenous transplantation. These results suggest that intravenous allogeneic transplantation of PDMCs promotes colon cancer progression and has a negative impact on survival of rats.

References

1 

Squillaro T, Peluso G and Galderisi U: Clinical trials with mesenchymal stem cells: An update. Cell Transplant. 25:829–848. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Mele V, Muraro MG, Calabrese D, Pfaff D, Amatruda N, Amicarella F, Kvinlaug B, Bocelli-Tyndall C, Martin I, Resink TJ, et al: Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β. Int J Cancer. 134:2583–2594. 2014. View Article : Google Scholar : PubMed/NCBI

3 

De Boeck A, Pauwels P, Hensen K, Rummens JL, Westbroek W, Hendrix A, Maynard D, Denys H, Lambein K, Braems G, et al: Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut. 62:550–560. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Katsuno T, Ochi M, Tominaga K, Tanaka F, Sogawa M, Tanigawa T, Yamagami H, Shiba M, Watanabe K, Watanabe T, et al: Mesenchymal stem cells administered in the early phase of tumorigenesis inhibit colorectal tumor development in rats. J Clin Biochen Nutr. 53:170–175. 2013. View Article : Google Scholar

5 

Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, Higashi Y, Tanaka S, Yasui W and Chayama K: Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer. 127:2323–2333. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Altobelli E, D'Aloisio F and Angeletti PM: Colorectal cancer screening in countries of european council outside of the EU-28. World J Gastroenterol. 22:4946–4957. 2016. View Article : Google Scholar : PubMed/NCBI

7 

American Cancer Society, . Colorectal Cancer Facts & Figures 2014–2016. simplehttps://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2014-2016.pdf

8 

Jackstadt R and Sansom OJ: Mouse models of intestinal cancer. J Pathol. 238:141–151. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Perše M and Cerar A: Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats. J Biomed Biotechnol. 2011:4739642011. View Article : Google Scholar : PubMed/NCBI

10 

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj and Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 8:315–317. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Mariotti E, Mirabelli P, Abate G, Schiattarella M, Martinelli P, Fortunato G, Di Noto R and Del Vecchio L: Comparative characteristics of mesenchymal stem cells from human bone marrow and placenta: CD10, CD49d and CD56 make a difference. Stem Cells Dev. 17:1039–1041. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, Qian H and Zhang X: Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells. Cell Biol Int. 30:681–687. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Hu J, Zhao G, Zhang L, Qiao C, Di A, Gao H and Xu H: Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis. Exp Ther Med. 12:2983–2989. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Svitina H, Kyryk V, Skrypkina І, Kuchma M, Bukreieva T, Areshkov P, Shablii Y, Denis Y, Klymenko P, Garmanchuk L, et al: Placenta-derived multipotent cells have no effect on the size and number of DMH-induced colon tumors in rats. Exp Ther Med. 14:2135–2147. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Kean TJ, Lin P, Caplan AI and Dennis JE: MSCs: Delivery routes and engraftment, cell-targeting strategies and immune modulation. Stem Cells Int. 2013:7327422013. View Article : Google Scholar : PubMed/NCBI

16 

Kurtz A: Mesenchymal stem cell delivery routes and fate. Int J Stem Cells. 1:1–7. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Zufferey R, Nagy D, Mandel RJ, Naldini L and Trono D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol. 15:871–875. 1997. View Article : Google Scholar : PubMed/NCBI

18 

Zhang J, Lv S, Liu X, Song B and Shi L: Umbilical cord mesenchymal stem cell treatment for crohn's disease: A randomized controlled clinical trial. Gut Liver. 12:73–78. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Silini AR, Cancelli S, Signoroni PB, Cargnoni A, Magatti M and Parolini O: The dichotomy of placenta-derived cells in cancer growth. Placenta. 59:154–162. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Rhee KJ, Lee JI and Eom YW: Mesenchymal stem cell-mediated effects of tumor support or suppression. Int J Mol Sci. 16:30015–30033. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Klopp AH, Gupta A, Spaeth E, Andreeff M and Marini F III: Concise review: Dissecting a discrepancy in the literature: Do mesenchymal stem cells support or suppress tumor growth? Stem Cells. 29:11–19. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Chen D, Liu S, Ma H, Liang X, Ma H, Yan X, Yang B, Wei J and Liu X: Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell Int. 15:422015. View Article : Google Scholar : PubMed/NCBI

23 

Ohta N, Ishiguro S, Kawabata A, Uppalapati D, Pyle M, Troyer D, De S, Zhang Y, Becker KG and Tamura M: Human umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genes. PLoS One. 10:e01237562015. View Article : Google Scholar : PubMed/NCBI

24 

Zheng H, Zou W, Shen J, Xu L, Wang S, Fu YX and Fan W: Opposite effects of coinjection and distant injection of mesenchymal stem cells on breast tumor cell growth. Stem Cells Transl Med. 4:1216–1228. 2016. View Article : Google Scholar

25 

O'Malley G, Heijltjes M, Houston AM, Rani S, Ritter T, Egan LJ and Ryan AE: Mesenchymal stromal cells (MSCs) and colorectal cancer: A troublesome twosome for the anti-tumour immune response? Oncotarget. 7:60752–60774. 2016.PubMed/NCBI

26 

Nasuno M, Arimura Y, Nagaishi K, Isshiki H, Onodera K, Nakagaki S, Watanabe S, Idogawa M, Yamashita K, Naishiro Y, et al: Mesenchymal stem cells cancel azoxymethane-induced tumor initiation. Stem Cells. 32:913–925. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Chen Z, He X, He X, Chen X, Lin X, Zou Y, Wu X and Lan P: Bone marrow mesenchymal stem cells ameliorate colitis-Associated tumorigenesis in mice. Biochem Biophys Res Commun. 450:1402–1408. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Sottoriva A, Kang H, Ma Z, Graham TA, Salomon MP, Zhao J, Marjoram P, Siegmund K, Press MF, Shibata D and Curtis C: A Big Bang model of human colorectal tumor growth HHS Public Access new model provides a quantitative framework to interpret tumor growth dynamics and the origins of ITH with significant clinical implications. Nat Genet. 47:209–216. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Nakagaki S, Arimura Y, Nagaishi K, Isshiki H, Nasuno M, Watanabe S, Idogawa M, Yamashita K, Naishiro Y, Adachi Y, et al: Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model. J Gastroenterol. 50:962–274. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Vulcano F, Milazzo L, Ciccarelli C, Eramo A, Sette G, Mauro A, Macioce G, Martinelli A, La Torre R, Casalbore P, et al: Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer. Exp Cell Res. 345:190–198. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Wu CG, Zhang JC, Xie CQ, Parolini O, Silini A, Huang YZ, Lian B, Zhang M, Huang YC and Deng L: In vivo tracking of human placenta derived mesenchymal stem cells in nude mice via 14C-TdR labeling. BMC Biotechnol. 15:552015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Svitina, H., Skrypkina, I., Areshkov, P., Kyryk, V., Bukreieva, T., Klymenko, P. ... Shablii, V. (2018). Transplantation of placenta‑derived multipotent cells in rats with dimethylhydrazine‑induced colon cancer decreases survival rate. Oncology Letters, 15, 5034-5042. https://doi.org/10.3892/ol.2018.7996
MLA
Svitina, H., Skrypkina, I., Areshkov, P., Kyryk, V., Bukreieva, T., Klymenko, P., Garmanchuk, L., Lobintseva, G., Shablii, V."Transplantation of placenta‑derived multipotent cells in rats with dimethylhydrazine‑induced colon cancer decreases survival rate". Oncology Letters 15.4 (2018): 5034-5042.
Chicago
Svitina, H., Skrypkina, I., Areshkov, P., Kyryk, V., Bukreieva, T., Klymenko, P., Garmanchuk, L., Lobintseva, G., Shablii, V."Transplantation of placenta‑derived multipotent cells in rats with dimethylhydrazine‑induced colon cancer decreases survival rate". Oncology Letters 15, no. 4 (2018): 5034-5042. https://doi.org/10.3892/ol.2018.7996